Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).
A retrospective chart review (RENALISTIC) evaluated first-line systemic treatment patterns and clinical outcomes in German patients with adv…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2 [Phase 2]
Phase 2 trial evaluating radiotherapy as an immunological booster in patients with metastatic melanoma or metastatic renal cell carcinoma tr…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC) [Phase 1]
Phase 1 safety and efficacy study of CTX130 in relapsed or refractory renal cell carcinoma (COBALT-RCC) has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) [Phase 2, Phase 3]
FRUSICA-2 is evaluating the combination of Fruquintinib and Sintilimab in advanced renal cell carcinoma, currently in Phase 2/Phase 3 with s…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma
Clinical trial results describe how axitinib dose reductions and temporary interruptions were used to manage adverse events in patients with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K) [NA]
A clinical trial entry for COMPAR-K is currently recruiting to compare outcomes across multiple platforms for assisted robotic kidney surger…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating talazoparib plus avelumab in metastatic renal cell carcinoma, including fumarate hydratase–deficient and…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors [Phase 2]
Ipsen-sponsored Phase 2 trial evaluating cabozantinib as second-line treatment for locally advanced or metastatic renal cell carcinoma with …
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney [Phase 3]
Phase 3 trial update comparing nivolumab alone or with ipilimumab to placebo in localized renal cell carcinoma after partial nephrectomy; re…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination
Ipsen announces a completed clinical trial evaluating cabozantinib in advanced renal cell carcinoma after first-line immuno-oncology checkpo…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. [Phase 1]
A Phase I/Ib trial of NZV930 alone and in combination with PDR001 and/or NIR178 in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Dendritic Cell Vaccination for Patients with Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 clinical study evaluating a dendritic cell vaccine in patients with solid tumors, including glioblastoma and renal cell carc…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: CD8 Minibody Repeatability Study [Phase 2]
ImaginAb's Phase 2 CD8 minibody repeatability study in melanoma and renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Study of NDI 1150-101 in Patients With Solid Tumors [Phase 1, Phase 2]
Nimbus Saturn, Inc. is conducting a Phase 1/2 trial of NDI 1150-101 in patients with solid tumors, including renal cell carcinoma, gastric c…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: TIL Therapy for Metastatic Renal Cell Carcinoma [Phase 1]
Phase 1 trial evaluating tumor-infiltrating lymphocyte therapy for metastatic renal cell carcinoma has completed; results were posted on 202…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy [Phase 2]
This Phase II trial evaluated Axitinib in patients with clear-cell metastatic renal cell carcinoma unsuitable for nephrectomy and has comple…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for the combination of sitravatinib and nivolumab in patients with advanced or metastatic renal cell carcinoma (incl…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma [Phase 1]
Phase I/Ib trial assessing the combination of pembrolizumab with vorinostat in patients with advanced renal cell carcinoma or bladder cancer…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: MEDI4736 Combinations in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial updates the use of durvalumab (MEDI4736) in combinations for metastatic renal cell carcinoma, with the study now completed. Co…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, and preliminary effectiveness of AGS-16C3F as monotherapy in renal cell carcinoma with cle…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]
A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. T…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) [Phase 3]
A randomized Phase 3 trial comparing avelumab with axitinib against sunitinib in advanced renal cell carcinoma has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CCT301 CAR-T therapy in adults with recurrent or refractory stage IV renal cell carcinoma has been ter…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
A clinical trial evaluating a multimodal predictive recurrence score for patients with renal cell carcinoma (clear cell subtype) has complet…